Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Aaron Lisberg's publication output changed over time?
ScholarIQpublication output · 2002–2025
Output grew100% over the shown period — from 1 works in 2002 to 2 in 2025.
1
1
1
1
1
2
2
2
20022016201720182019202320242025
What are the most-cited papers on Aaron Lisberg?
ScholarIQmost cited works
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Yuehua Jiang, Balkrishna Jahagirdar, R. Lee Reinhardt, Robert E. Schwartz, C. Dirk Keene, Xilma R. Ortiz‐González, Morayma Reyes, Todd Lenvik, Troy C. Lund, Mark Blackstad, Jingbo Du, Sara Aldrich, Aaron Lisberg, Walter C. Low, David A. Largaespada, Catherine M. Verfaillie
Nature. 20025,532 Citations
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan, Darlene Veruttipong, Jonathan W. Goldman, Silvia C. Formenti, Edward B. Garon, Percy Lee
The Lancet Oncology. 20171,094 Citations
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC
Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman, Krikor Bornazyan, Nicholas Reese, T. Wang, Paul Coluzzi, Blanca Ledezma, Melody Mendenhall, J.S. Hunt, Brian R. Wolf, Benjamin Jones, John Madrigal, John M. Horton, Marshall L. Spiegel, James Carroll, Jaklin Gukasyan, T.J. Williams, L. Sauer, Courtney Wells, Ariana Hardy, Paulina Linares, Chong-Hee Lim, Lin Ma, Carlos Adame, Edward B. Garon
Journal of Thoracic Oncology. 2018596 CitationsOPEN ACCESS
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
Katherine Hastings, Helena A. Yu, Wen Wei, Francisco Sánchez-Vega, Michelle DeVeaux, Jungmin Choi, Hira Rizvi, Aaron Lisberg, Anna Truini, Christine Lydon, Z. Liu, Brian S. Henick, Anna Wurtz, Guoping Cai, Andrew J. Plodkowski, Niamh M. Long, Darragh Halpenny, Jonathan Killam, I Oliva, Nikolaus Schultz, Gregory J. Riely, Maria E. Arcila, Marc Ladanyi, D. Zelterman, Roy S. Herbst, Sarah B. Goldberg, Mark M. Awad, Edward B. Garon, Scott Gettinger, Matthew D. Hellmann, Katerina Politi
Annals of Oncology. 2019372 CitationsOPEN ACCESS
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons‐Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, M. Pérol, Céline Mascaux, Elena Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Min Hee Hong, Enriqueta Felip, Richard D. Hall, Óscar Juan, Daniel Brungs, Shun Lü, Marina Chiara Garassino, Michael Chargualaf, Yong Zhang, Paul Howarth, Deise Uema, Aaron Lisberg, Jacob Sands, for the TROPION-Lung01 Trial Investigators, Gastón Lucas Martinengo, Juan Puig, Daniel Brungs, Bo Gao, Adnan Nagria, Christos S. Karapetis, Sagun Parakh, Cheol Park, Gaëtan Catala, Frédéric Forget, Sebahat Ocak, Naveen S. Basappa, Geoffrey Liu, Ines B. Menjak, Benjamin Shieh, Shun Lü, Feng Luo, Hongmei Sun, Jialei Wang, Yu Yao, Milada Zemanová, Jaafar Bennouna, Nicolas Girard, Laurent Greillier, Corinne Lamour, H. Léna, Céline Mascaux, Julien Mazières, Denis Moro‐Sibilot, M. Pérol, Elvire Pons‐Tostivint, Virginie Westeel, Akin Atmaca, Christine Greil, Niels Reinmuth, Christian Schumann, Thomas Wehler, Juergen Wolf, James Ho, Csaba Böcskei, Federico Cappuzzo, Filippo de Marinis, Claudia Proto, Manlio Mencoboni, Silvia Novello, Stefania Salvagni, Héctor Soto Parrà, Haruko Daga, Yasushi Goto, Hidetoshi Hayashi, Satoru Kitazono, Kiyotaka Yoh, Ryo Ko, Masashi Kondo, Toshiyuki Kozuki, Takayasu Kurata, Hideaki Mizutani, Kadoaki Ohashi, Satoshi Oizumi, Isamu Okamoto, Satoshi Sakaguchi, H Ozasa, Shunichi Sugawara, Yuichi Tambo, Motohiro Tamiya, Hiroshi Tanaka, Isamu Okamoto, Froylán López-López, Francisco Javier Ramírez Godinez, Jerónimo Rafael Rodríguez Cid, Robin Cornelissen, Steven Gans
Journal of Clinical Oncology. 2024209 CitationsOPEN ACCESS
Related on ScholarIQ
APLA Health
Institution
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Paper
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Paper
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC
Paper
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
Paper
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
Paper